650577-84-7Relevant articles and documents
Receptor-Type Kinase Modulators and Methods of Use
-
Paragraph 0368, (2016/06/06)
The present invention provides compounds for modulating receptor kinase activity, particularly ephrin and EGFR, and methods of treating diseases mediated by receptor kinase activity utilizing the compounds and pharmaceutical compositions thereof. Diseases
C-MET MODULATORS AND METHOD OF USE
-
Page/Page column 74, (2010/10/19)
-